Search in:

Advanced search

Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 8

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Research

Patent Update Anti-infectives: Developments in herpesviruses 1995

Gerald Gough Gerald Gough & Paul W Smith, Glaxo Wellcome Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK

Paul W Smith Glaxo Wellcome Medicines Research Centre, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK

Pages 753-763 | Published online: 29 Feb 2008

Cite this article
https://doi.org/10.1517/13543776.6.8.753

References
Citations
Metrics
Reprints & Permissions

References to Primary Literature

ROCK DL: The molecular basis of latent infections by alphaherpesviruses. Semin. Virol. (1993) 4:157–165.
Web of Science ®Google Scholar
FAWL RL, ROIZMAN 13: The molecular basis of herpes simplex virus pathogenicity. Semin. Virol. (1994) 5:261–271.
Web of Science ®Google Scholar
AHMED R, MORRISON LA, KNIPE DM: Persistence of viruses. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):219–250.
Google Scholar
ROIZMAN B, SEARS AE: Herpes simplex viruses and their replication. In: The Human Herpes Viruses. Roizman B, Lopez C, Whitley RJ (Eds.), Raven Press, New York (1993):11–16.
Google Scholar
WARD PL, ROIZMAN B: Herpes simplex genes: blueprint for a successful human pathogen. Trends Genetics (1994) 10:267–274.
PubMed Web of Science ®Google Scholar
CHA TA, TOM E, KEMBLE GW et al.: Human cytomega-lovirus clinical isolates carry at least 19 genes not found In laboratory strains. J. Virol. (1996) 70:78–83.
PubMed Web of Science ®Google Scholar
MESRI EA, CESARMEN E, ARVANITAKIS L et al.: Human herpes virus-8 Kaposi's sarcoma-associated herpes-virus is a new transmissible virus that infects B cells. Exp. Med. (1996) 183:2385–2390.
PubMed Web of Science ®Google Scholar
WHITE DO, FENNER FJ: Herpesviridae. In: Medical Virol-ogy. White DO, Fenner FJ (Eds.), Academic Press (1994):318–347.
Google Scholar
SACKS L, ALRABIAH F: Novel herpes treatments: a re-view. Exp. Opin. Invest. Drugs (1996) 5:169–183.
Google Scholar
BEUTNER KR: Valacklovir: a review of its antiviral activ-ity, pharmacokinetic properties, and clinical efficacy. Antiviral Res. (1995) 28:281–290.
PubMed Web of Science ®Google Scholar
CIRELLI R, HERNE K, MCCRARY M, LEE P, TYRING SK: Fanwiclovir: a review of clinical efficacy and safety. Antiviral Res. (1996) 29:141–151.
PubMed Web of Science ®Google Scholar
ARVIN AM: Varicella-zoster virus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2547–2586.
Google Scholar
ARVIN AM, MOFFAT JF, REDMAN R: Varicella-zoster virus: aspects of pathogenesis and the host response to natu-ral infection and varicella vaccine. Adv. Viral Res. (1996) 46:265–307
Web of Science ®Google Scholar
COHEN JI, STRAUS SE: Varicella-zoster virus and its replication- In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York. (1996):2525–2546.
Google Scholar
NIKKELS AF, PIERARD GE: Current therapies for shin-gles. Exp. Opin. Invest. Drugs (1996) 5:185–196.
Google Scholar
BRITT WJ, ALFORD CA: Cytomegalovirus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2493–2524.
Google Scholar
MELNICK JL, ADAM E, DEBAKEY ME: Cytomegalovirus and atherosclerosis. BioEssays (1995) 17:899–903.
PubMed Web of Science ®Google Scholar
PLACHTER B, SINZGER C, JAHN G: Cell types involved in replication and distribution of human cytomega-lovirus. Adv. Viral. Res. (1996) 46:197–241.
Web of Science ®Google Scholar
FISH KN, BRITT W, NELSON JA: A novel mechanism for persistence of human cytomegalovirus in macro-phages.]. Virol. (1996) 70: 1855-1862.
Google Scholar
RONDO K, KANESHIMA H, MOCARSKI ES: Human cy-tomegalovirus latent infection of granulocyte-macro-phage progenitors. Proc. Natl. Acad. Sci. USA (1994) 91:11879–11883.
PubMed Web of Science ®Google Scholar
STENBERG RM, KERRY JA: Cytomegalovirus genes: their structure and function. Scand. J. Infect. Dis . (1995) S99:3–6.
Google Scholar
MOCARSKI ES: Cytomegaloviruses and their replication. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2447–2492.
Google Scholar
GRIFFITHS PD: Parameters for the successful manage-ment of cytomegalovirus. Antiviral Chem. Chemother. (1995) 6\(Suppl. 1):7–11.
Google Scholar
YOUNG LS: Epstein-Barr virus: general features. In: Encyclopedia of Virology. Webster RG, Granoff A (Eds.), Academic Press (1995):404–409.
Google Scholar
RICKINSON AB, KIEFF E: Epstein-Barr virus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2397–2446
Google Scholar
THOMAS JA, ALLDAY MJ, CRAWFORD DH: Epstein-Barr virus-associated lymphoproliferative disorders in fin-munocompromised individuals. Adv. Cancer Res. (1991) 57:329–380.
PubMed Web of Science ®Google Scholar
KLEIN G: Viral latency and transformation: the strategy of Epstein-Barr virus. Cell (1989) 58:5–8.
PubMed Web of Science ®Google Scholar
KIEFF E: Epstein-Barr virus and its replication. In: Virol-ogy. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Ra-ven Press, New York (1996):2343–2396.
Google Scholar
YAMANISHI K: Human herpesvirus 6. Int. Antiviral News (1996) 4:59–60.
Google Scholar
LUSSO P: Human herpesvirus 6 (HHV-6). Antiviral Res. (1996) 31:1–21.
PubMed Web of Science ®Google Scholar
KRUEGER GRF, KLUEPPELBERG U, HOFFMAN A, ABLASHI DV: Clinical correlates of infection with human herpes-virus-6. In Vivo (1994) 8:457–486.
PubMedGoogle Scholar
CHALLONER PB, SMITH KT, PARKER JD et al.: Plaque-as-sociated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA (1995) 92:7440–7444.
PubMed Web of Science ®Google Scholar
HERNDON RM: Herpesviruses in multiple sclerosis. Arch. Neurol. (1996) 53:123–124.
PubMedGoogle Scholar
LUSSO P, GALLO RC: Human herpesvirus 6 in AIDS Immunol. Today (1995) 16:67–71.
Google Scholar
FRENICEL N, ROFFMAN E: Human herpesvirus 7. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippin-cott-Raven Press, New York (1996):2609–2622.
Google Scholar
AMBROZIAK JA, BLACKBOURN DJ, HERNDIER BG et aL: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 268:582–583.
PubMed Web of Science ®Google Scholar
Herpes viruses. In: Antiviral Chemotherapy. Jeffries DJ, DeClercq E (Eds.), J Wiley 8r Sons (1995):81–284.
Google Scholar
DUTIA BM: Ribonucleotide reductase induced by herpes simplex virus has a virus specified constituent.]. Gen. Virol. (1993) 64:513–521
Web of Science ®Google Scholar
BRANDT C.R, SPENCER B, IMESCH P, GARNEAU M, DEZLEL R: Evaluation of a peptidomimetic ribonucleotide re-ductase inhibitor with a murine model of herpes sim-plex virus type 1 ocular disease, Antimicrobial Agents Chernother. (1996) 40:1078-1084. and analysis of the human cytomegalovirus UL80-en-
Google Scholar
BAUM EZ, BEBERNITZ GA, HULMES JD et a/ Expression and analysis of the human cytomegalovirus WO-encoded protease: identification of autoproteolytic sites.
Google Scholar
FRUH K, AHN K, DJABALLAH H el a1 Aviral inhibitor of peptide transporters for antigen presentation Nature 1 Mwl (1993) 67 497–506 (1995) 375 415–418
Google Scholar
FRIEDLAND JS Chemoklnes in vlial disease. Res Vzml (1996) 147 131–138
Google Scholar
MEINI E, FICKENSCHER �1, FLECKENSTEIN B Chemokine receptors and chemoklne-inducing molecuies of lymphotrophic herpesviruses. Immunol Today (1996) 17 199
PubMedGoogle Scholar
WIERTZ EJHJ, JONES TR, LEI SUN el a1 The human cytomegalovjrus US11 gene produd dislocates MHC c h s 1 heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 84 769–779
PubMed Web of Science ®Google Scholar
FARREL HE, MCLEAN CS, EFSTATHIOU S, INGLIS S, MIN SON AC Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deletea/
Google Scholar
LIU F, ROIZMAN B The promoter, transcription unlt and coding sequences of herpes simplex virus 1 family 35 proteins are contained withb and in frame with the u1.26 open reading Erame. J Mml (1991) 65 206–212
Google Scholar

References to Patent Literature

KOBAYASHI KAKO KK, JP7247216 (1995).
Google Scholar
ZYMA SA, GB2288734 (1995).
Google Scholar
ZYMA SA, EP-679390 (1995).
Google Scholar
DR RENTSCHLER ARZNEIMITTEL GMBH & CO., W09531201 (1995).
Google Scholar
WELLCOME FDN. LTD., W09505179 (1995).
Google Scholar
SMITHKLINE BEECHAM PLC., GB2282759 (1995).
Google Scholar
HOECHST AG, EP-661058 (1995).
Google Scholar
SMITHKLINE BEECHAM PLC., W09513073 (1995).
Google Scholar
SMITHKLINE BEECHAM PLC., W09513074 (1995).
Google Scholar
SMITHKLINE BEECHAM PLC., W09509632 (1995).
Google Scholar
SMlTHKLINE BEECHAM PLC., W09517190 (1995).
Google Scholar
F HOFFMANN-LA ROCHE AG, EP-694547 (1995).
Google Scholar
BRISTOL-MYERS SQUIBB CO., EP-63W97 (1995).
Google Scholar
BRISTOL-MYERS SQUIBB CO., US5414000 (1995).
Google Scholar
BRISTOL-MYERS SQUIBB CO., US5414096 (1995).
Google Scholar
BURROUGHS WELLCOME CO., US5399580 (1995).
Google Scholar
WELLCOME FDN. LTD., W09601833 (1995).
Google Scholar
AJINOMOTO CO., INC., EP-649840 (1995).
Google Scholar
AJINOMOTO CO., INC., EP454473 (1995).
Google Scholar
BORWNG PHARM CO. LTD., EP-657465 (1995).
Google Scholar
NIPPON KAYAKU KK, JP7126282 (1995).
Google Scholar
ELI LILLY & CO., US5430026 (1995).
Google Scholar
CIBA-GEIGY AG, EP-629633 (1995).
Google Scholar
DAIICHI SEIYAKU KK, JP7048374 (195).
Google Scholar
MITSUBISHI KASEI COW., EP-632048 (1995).
Google Scholar
GENSET, W09504141 (1995).
Google Scholar
ROMAN KOGYO KK, JP7206892 (1995).
Google Scholar
ISISPIIARM, INC., W09528341 (1995).
Google Scholar
ISISPHARM, INC., US5442049 (1995).
Google Scholar
HYBRIDON, INC., W09532213 (1995).
Google Scholar
HYBRIDON, INC., W09522554 (1995).
Google Scholar
ISISPHARM, INC., W09526204 (1995).
Google Scholar
BIO-MEGA, US5484771 (1995).
Google Scholar
GIBSON DW, US543074 (1995).
Google Scholar
GD SEARLE, W09529897 (1995).
Google Scholar
SEIGAKU CORP., W09427607 (195).
Google Scholar
UNIVERSITY OF MICHIGAN, W09523151 (1995).
Google Scholar
SRI INTERNATIONAL, W09504059 (1995).
Google Scholar
SCHERING CORP., US5459146 (1995).
Google Scholar
SHOWA SHELL SEKIYU KK, JP7070166 (1995).
Google Scholar
SOYAKU GIJUTSU KENKYUJO KK, JP7277963 (1995).
Google Scholar
SANWA KAGAKU KENKYUJO KK, JP635748 (1995).
Google Scholar
WELLCOME FDN. LTD., W09507910 (1995).
Google Scholar
NIPPON SHOJI KK, JP179467 (1995).
Google Scholar
ALLELIX BIOPHARM, INC., W09511038 (1995).
Google Scholar
BAYER AG, EP-611776 (1995).
Google Scholar
ALLELIX BIOPHARM, INC., W09514027 (1995).
Google Scholar
COMMONWEALTH SCI. & IND. RES. ORG., W09531202 (1995).
Google Scholar
SCOTGEN PHARM., INC., W09531546 (1995).
Google Scholar
AND02 PHARM. CORP., W09504080 (1995).
Google Scholar
SCRIPPS RES. INST., W09518634 (1995).
Google Scholar
MERCK & CO., INC., W09517503 (1995).
Google Scholar
BRITISH BIOTECH PHARM. LTD., W09601900 (196).
Google Scholar
AVIRON, W09529991 (1995).
Google Scholar
SMITHKLINE BEECHAM CORP., W09506055 (1995).
Google Scholar
AUSTRALIAN NATIONAL UNIVERSm, W09514487 (1995).
Google Scholar
SMWHKUNE BEECIIAM BIOLOGICALS SA, W09516779 (1995).
Google Scholar
QUEENSIAND INST. OF MED. RES., W09524925 (1995).
Google Scholar
AMRON, W09528488 (1995).
Google Scholar
SMITHKLINE BEECHAM BIOLOGICALS SA, W09531555 (1995).
Google Scholar
CANTAB PHARM. RES. LTD., W0950339 (1995).
Google Scholar
HARVARD COLLEGE, W09518852 (1995).
Google Scholar
MRC, W09520049 (1995).
Google Scholar
PHARMA MAR SA, EP-647645 (1995).
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Patent Update Anti-infectives: Developments in herpesviruses 1995

References to Primary Literature

References to Patent Literature

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patent Update Anti-infectives: Developments in herpesviruses 1995

References to Primary Literature

References to Patent Literature

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date